Some $3bn (£2.4bn) will be invested over the next 10 years to end vaccine dependency across the continent, the Africa Development Bank (AfDB) has pledged.
The plan includes a new pharmaceutical centre for research, development and manufacturing based in Rwanda's capital, Kigali.
It has been widely lauded as key towards ending Africa’s dependence on outside donations, as recently witnessed during the Covid-19 pandemic
AfDB says it will also help patent and license African-made medicines, and support governments to navigate the intellectual property rights to global vaccines and medicines.
It follows a recent World Trade Organisation announcement of a partial waiver on coronavirus vaccine patents, allowing select developing countries to produce the jabs.
AfDB says Africa currently imports more than 70% of all its medicines, spending about $14bn every year.
Latest Stories
-
Akufo-Addo commissions 200MW plant to boost economic growth
4 hours -
Smallholder farmers to make use of Ghana Commodity Exchange
4 hours -
I want to focus more on my education – Chidimma Adetshina quits pageantry
4 hours -
Priest replaced after Sabrina Carpenter shoots music video in his church
4 hours -
Duct-taped banana artwork sells for $6.2m in NYC
4 hours -
Arrest warrants issued for Netanyahu, Gallant and Hamas commander over alleged war crimes
4 hours -
Actors Jonathan Majors and Meagan Good are engaged
5 hours -
Expired rice saga: A ‘best before date’ can be extended – Food and Agriculture Engineer
5 hours -
Why I rejected Range Rover gift from a man – Tiwa Savage
5 hours -
KNUST Engineering College honours Telecel Ghana CEO at Alumni Excellence Awards
5 hours -
Postecoglou backs Bentancur appeal after ‘mistake’
5 hours -
#Manifesto debate: NDC to enact and pass National Climate Law – Prof Klutse
6 hours -
‘Everything a manager could wish for’ – Guardiola signs new deal
6 hours -
TEWU suspends strike after NLC directive, urges swift resolution of grievances
6 hours -
Netflix debuts Grain Media’s explosive film
6 hours